Artifactual Depression of Serum Glutamic Oxaloacetic Transaminase by Metronidazole

Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole therapy. Metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Rissing, J. Peter, Newman, Cheryl, Moore, William L.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1978
Matèries:	Pharmacology and Therapeutics
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352522/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/214030/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.14.4.636
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!